98%
921
2 minutes
20
Rationale: Monitoring clinical outcomes in persistent spinal pain syndrome type 2 (PSPS-T2) varies widely owing to the refractory nature and diverse treatment strategies. Furthermore, it is unclear which outcome domains are most important from the perspective of the patient with PSPS-T2. In a previous scoping review, we identified patient-relevant outcome domains. The objective of this study was to prioritize patient-relevant outcome domains for PSPS-type 2.
Materials And Methods: Four focus groups with patients with PSPS-T2 were conducted; two groups comprised patients who were treated with spinal cord stimulation (SCS), and two groups comprised patients without SCS. Outcome domains identified through prior research and newly emerged ones were discussed and prioritized using a Nominal Group Technique. Results from the ranking assignments were analyzed, and a qualitative content analysis was performed to value important outcome domains.
Results: Overall, 34 patients with PSPS-T2 participated, 18 of whom were treated with SCS. The five highest ranked outcome domains were "pain," "daily activities," "sleep," "social participation," and "self-reliance." In the qualitative analysis, specific outcome domains emerged as prominent themes: pain, "physical activities," "coping with the illness," "acceptance," and "social participation". In addition, the participants expressed a desire for increased understanding, better acknowledgment of their condition, and gaining perspective during the care process.
Conclusions: The highest valued outcome domains for patients with PSPS-T2 are pain, daily/physical activities, sleep, social participation, self-reliance, coping with the illness, and acceptance. These can be considered for future health care evaluation of patients with PSPS-T2. More research is needed to determine adequate measurement tools for the development of a core outcome set.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neurom.2025.07.002 | DOI Listing |
J Alzheimers Dis
September 2025
Paula Costa-Urrutia Medical Affairs, Terumo BCT, Edificio Think MVD, Montevideo, Uruguay.
BackgroundTherapeutic plasma exchange (TPE) with albumin replacement has emerged as a potential treatment for Alzheimer's disease (AD). The AMBAR trial showed that TPE could slow cognitive and functional decline, along with changes in core and inflammatory biomarkers in cerebrospinal fluid.ObjectiveTo evaluate the safety and effectiveness of TPE in a real-world setting in Argentina.
View Article and Find Full Text PDFInt Urogynecol J
September 2025
Department of Public Health Sciences, University of Connecticut School of Medicine, Farmington, CT, USA.
Introduction And Hypothesis: Depressive and anxiety symptoms are known risk factors for lower urinary tract symptoms (LUTS). To inform prevention and treatment strategies, this research examined whether greater emotional support seeking weakened associations of affective symptoms with LUTS and poorer bladder health.
Methods: Data were collected from women in the USA who participated in the RISE FOR HEALTH study of bladder health.
Disabil Rehabil Assist Technol
September 2025
Department of Special Needs Education and Rehabilitation, Department Pedagogy and Didactics for People with Physical and Motor Development Impairments and Chronic and Progressive Illnesses, Carl von Ossietzky University, Oldenburg, Germany.
Objectives: Many studies investigate the impact of assistive devices and technologies (AD/AT) on physical outcomes. The role of AD/ATs in everyday activities and participation of children with cerebral palsy (CP) has received much less attention. This review scopes the impact of AD/ATs by the activities and participation components of the International Classification of Functioning, Disability and Health (ICF) model.
View Article and Find Full Text PDFProbiotics Antimicrob Proteins
September 2025
Operational Research Centre in Healthcare, Near East University, Nicosia, Cyprus.
Probiotics are live beneficial microorganisms that confer health benefits to the host when administered in adequate amounts, have gained considerable scientific and commercial interest for their ability to support gut health, strengthen immunity, and reduce disease risk. This review traces the genesis of probiotic science from its origins in traditional fermented foods to contemporary clinical applications, offering a conceptual understanding of its evolution. A clear distinction is drawn between endogenous probiotics, naturally resident in the human microbiome, and exogenous probiotics, introduced via dietary supplements and functional foods.
View Article and Find Full Text PDFInflammopharmacology
September 2025
Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, 140401, India.
The NOD‑like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a key molecular complex that amplifies inflammatory cascades by maturing interleukin‑1 beta (IL-1β) and interleukin‑18 (IL-18) and inducing pyroptosis. It serves as a major driver and co-driver of numerous diseases associated with chronic inflammation. Dysregulated NLRP3 activation contributes to the progression of disorders such as rheumatoid arthritis, inflammatory bowel disease, neurodegenerative diseases and atherosclerosis.
View Article and Find Full Text PDF